Research Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.’s FY2017 Earnings (ZBH)

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) – William Blair dropped their FY2017 earnings per share estimates for shares of Zimmer Biomet Holdings in a note issued to investors on Wednesday. William Blair analyst K. Krum now forecasts that the medical equipment provider will earn $8.03 per share for the year, down from their previous estimate of $8.20. William Blair also issued estimates for Zimmer Biomet Holdings’ Q4 2017 earnings at $2.10 EPS, Q1 2018 earnings at $1.98 EPS, Q2 2018 earnings at $2.00 EPS, Q3 2018 earnings at $1.98 EPS, Q4 2018 earnings at $2.24 EPS and FY2018 earnings at $8.20 EPS.

Several other equities analysts have also issued reports on ZBH. Piper Jaffray Companies lowered Zimmer Biomet Holdings from an “overweight” rating to a “neutral” rating in a research note on Thursday. Jefferies Group LLC reissued a “buy” rating and set a $136.00 target price on shares of Zimmer Biomet Holdings in a research note on Friday. Oppenheimer Holdings, Inc. set a $137.00 target price on Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Monday, August 14th. SunTrust Banks, Inc. set a $136.00 target price on Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Wednesday, November 1st. Finally, Morgan Stanley decreased their target price on Zimmer Biomet Holdings from $146.00 to $136.00 and set an “overweight” rating on the stock in a research note on Thursday. Three research analysts have rated the stock with a sell rating, nine have given a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $134.75.

WARNING: “Research Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.’s FY2017 Earnings (ZBH)” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.com-unik.info/2017/11/06/research-analysts-issue-forecasts-for-zimmer-biomet-holdings-inc-s-fy2017-earnings-zbh.html.

Zimmer Biomet Holdings (ZBH) opened at $109.25 on Monday. Zimmer Biomet Holdings has a 12 month low of $95.63 and a 12 month high of $133.49. The company has a quick ratio of 0.80, a current ratio of 1.47 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $22,089.91, a price-to-earnings ratio of 13.54, a PEG ratio of 1.48 and a beta of 1.17.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. The business had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. During the same period last year, the company earned $1.79 EPS. The business’s revenue for the quarter was down .8% on a year-over-year basis.

Several institutional investors and hedge funds have recently added to or reduced their stakes in ZBH. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Zimmer Biomet Holdings by 25.3% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 167 shares during the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of Zimmer Biomet Holdings by 3.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after acquiring an additional 33 shares during the last quarter. IHT Wealth Management LLC increased its holdings in shares of Zimmer Biomet Holdings by 28.4% in the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock valued at $139,000 after acquiring an additional 256 shares during the last quarter. BB&T Investment Services Inc. purchased a new position in shares of Zimmer Biomet Holdings in the 2nd quarter valued at about $144,000. Finally, Sandy Spring Bank increased its holdings in shares of Zimmer Biomet Holdings by 5.4% in the 2nd quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock valued at $166,000 after acquiring an additional 66 shares during the last quarter. Institutional investors and hedge funds own 85.26% of the company’s stock.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Earnings History and Estimates for Zimmer Biomet Holdings (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit